» Articles » PMID: 38498958

Vaporized D-limonene Selectively Mitigates the Acute Anxiogenic Effects of Δ9-tetrahydrocannabinol in Healthy Adults Who Intermittently Use Cannabis

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2024 Mar 18
PMID 38498958
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cannabis contains hundreds of chemical constituents beyond delta-9-tetrahydrocannabinol (THC), which is believed to drive most of its acute pharmacodynamic effects. The entourage effect theory asserts that non-THC constituents can impact acute cannabis effects, but few empirical studies have systematically evaluated this theory in humans. This study assessed whether the cannabis terpenoid d-limonene mitigates the acute anxiogenic effects of THC.

Methods: Twenty healthy adults completed nine, double-blind outpatient sessions in which they inhaled vaporized THC alone (15mg or 30mg), d-limonene alone (1mg or 5mg), the same doses of THC and d-limonene together, or placebo; a subset of participants (n=12) completed a tenth session in which 30mg THC+15mg d-limonene was administered. Outcomes included subjective drug effects, cognitive/psychomotor performance, vital signs, and plasma THC and d-limonene concentrations.

Results: When d-limonene was administered alone, pharmacodynamic outcomes did not differ from placebo. Administration of 15mg and 30mg THC alone produced subjective, cognitive, and physiological effects typical of acute cannabis exposure. Ratings of anxiety-like subjective effects qualitatively decreased as d-limonene dose increased and concurrent administration of 30mg THC+15mg d-limonene significantly reduced ratings of "anxious/nervous" and "paranoid" compared with 30mg THC alone. Other pharmacodynamic effects were unchanged by d-limonene. D-limonene plasma concentrations were dose orderly, and concurrent administration of d-limonene did not alter THC pharmacokinetics.

Conclusions: D-limonene selectively attenuated THC-induced anxiogenic effects, suggesting this terpenoid could increase the therapeutic index of THC. Future research should determine whether this effect extends to oral dose formulations and evaluate the interactions between other cannabis terpenoids or cannabinoids and THC.

Citing Articles

Cannabis: Zone Aspects of Raw Plant Components in Sport-A Narrative Review.

Flangea C, Vlad D, Popescu R, Dumitrascu V, Rata A, Tryfon M Nutrients. 2025; 17(5).

PMID: 40077729 PMC: 11902196. DOI: 10.3390/nu17050861.


Somatic Mutation Accumulations in Micropropagated Cannabis Are Proportional to the Number of Subcultures.

Adamek K, Jones A, Torkamaneh D Plants (Basel). 2024; 13(14).

PMID: 39065436 PMC: 11279941. DOI: 10.3390/plants13141910.


Data on terpene content in pre-rolled cone paper infused with terpene-containing flavours based on the formation of a partially soluble precipitate.

Karangan A, Rahardjo S, Widagdo A, Santoso S, Ismadji S Data Brief. 2024; 55:110623.

PMID: 38993226 PMC: 11237848. DOI: 10.1016/j.dib.2024.110623.


The Effect of Cannabidiol on Subjective Responses to Endurance Exercise: A Randomised Controlled Trial.

McCartney D, Irwin C, Bawa Z, Palmer B, Sahinovic A, Delang N Sports Med Open. 2024; 10(1):61.

PMID: 38782848 PMC: 11116295. DOI: 10.1186/s40798-024-00727-3.

References
1.
Spindle T, Martin E, Grabenauer M, Woodward T, Milburn M, Vandrey R . Assessment of cognitive and psychomotor impairment, subjective effects, and blood THC concentrations following acute administration of oral and vaporized cannabis. J Psychopharmacol. 2021; 35(7):786-803. PMC: 9361180. DOI: 10.1177/02698811211021583. View

2.
Cash M, Cunnane K, Fan C, Romero-Sandoval E . Mapping cannabis potency in medical and recreational programs in the United States. PLoS One. 2020; 15(3):e0230167. PMC: 7098613. DOI: 10.1371/journal.pone.0230167. View

3.
Komiya M, Takeuchi T, Harada E . Lemon oil vapor causes an anti-stress effect via modulating the 5-HT and DA activities in mice. Behav Brain Res. 2006; 172(2):240-9. DOI: 10.1016/j.bbr.2006.05.006. View

4.
Pertwee R . Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. Addict Biol. 2008; 13(2):147-59. DOI: 10.1111/j.1369-1600.2008.00108.x. View

5.
Bhattacharyya S, Egerton A, Kim E, Rosso L, Riano Barros D, Hammers A . Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors. Sci Rep. 2017; 7(1):15025. PMC: 5670208. DOI: 10.1038/s41598-017-14203-4. View